December 2020 FDA Recall Sodium Chloride by Hikma Pharmaceuticals Usa Inc.
D-0169-2021 - Failed pH Specifications

This Class II drug recall was voluntarily initiated by Hikma Pharmaceuticals Usa Inc. on December 7, 2020 for the product Sodium Chloride. The FDA reported the reason for recall as failed ph specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0169-2021

Reason for Recall
Failed pH Specifications: Out of Specification pH Test Results were found in Sodium Chloride Injection USP 0.9% 2ml vial.
Initiated
12-07-2020
Reported
12-23-2020
Quantity
1,324,072 vials

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Hikma Pharmaceuticals USA Inc.
Distributed Nationwide in the USA
Sodium Chloride Injection, USP, 0.9%, 0.308 mOsmol/ml, 2mL Single Dose Vial, Rx Only, Mfd. by. West-ward Eatontown, NJ 07724 USA, Vial NDC 0641-0497-17

Batch or Lot Expiration Information

Lot# : 048315 EXP 4/2021; 068320 EXP 6/2021; 128302 EXP 12/2021; 099349 EXP 9/2022.